TYCC
LUMO

Texas Yale Capital Corp’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Texas Yale Capital Corp’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,000
Closed -$571K – 457
2020
Q4 		$571K Hold
16,000
– – 0.04% 293
2020
Q3 		$221K Buy
16,000
+1,000
+7% +$14.9K 0.02% 387
2020
Q2 		$247K Buy
+15,000
New +$179K 0.02% 370

Other funds holding LUMO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Texas Yale Capital Corp's LUMO Position: Q1 2021 in Review

Texas Yale Capital Corp sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2021, closing a stake of 16,000 shares — an estimated $571K sold.

Texas Yale Capital Corp first reported a position in LUMO in Q2 2020 and held it in 3 quarters. The position peaked at $571K in Q4 2020. 41 funds tracked by Wall St. Rank hold LUMO as of Q1 2021.

  • Texas Yale Capital Corp reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Texas Yale Capital Corp sold 16,000 Lumos Pharma, Inc. Common Stock shares in Q1 2021, an estimated $571K.
  • Texas Yale Capital Corp first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Texas Yale Capital Corp's Lumos Pharma, Inc. Common Stock position peaked at $571K in Q4 2020.
  • 41 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2021.

Based on Texas Yale Capital Corp's 13F filing for Q1 2021, filed 12 May 2021.